clinicaltrialsarena4h
Palisade Bio begins MAD cohorts of Phase Ia/b ulcerative colitis therapy trial
Palisade Bio has begun the multiple ascending dose (MAD) cohorts of its ongoing Phase Ia/b trial of PALI-2108 for ulcerative ...
clinicaltrialsarena7h
Boehringer Ingelheim announces Phase III schizophrenia failures
The company said that all of its CONNEX trials failed to meet expectations showing no impact on patients living with ...
clinicaltrialsarena8h
Avacta Therapeutics reports data from trial of AVA6000 for salivary gland cancer
Avacta Therapeutics has reported outcomes from the Phase Ia trial of AVA6000, a drug candidate for solid tumours.
clinicaltrialsarena10h
Ocugen doses first subject in Phase I trial of diabetic macular oedema treatment
Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic macular oedema (DMO) treatment.